BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9259847)

  • 1. Platelet apheresis for extreme thrombocytosis in an 11-year-old girl with CML.
    McCarthy LJ; Graves VL; Eigen H; McGuire WA
    Transfus Med; 1991 Sep; 1(3):187-9. PubMed ID: 9259847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
    Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
    Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet apheresis for digital gangrene due to thrombocytosis in chronic myeloid leukaemia.
    Win N; Mitchell DC
    Clin Lab Haematol; 2001 Feb; 23(1):65-6. PubMed ID: 11422234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Chronic Myeloid Leukemia Presenting With Extreme Thrombocytosis Simulating Essential Thrombocythemia.
    Boklan JL; Walsh AM; de la Maza MC; Su LL; Nizzi FA; Schafernak KT
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):456-457. PubMed ID: 29668550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombocytosis in chronic myelogenous leukemia (CML) controlled by interferon alpha (IFN-alpha)].
    Koike G; Otsuka T; Shibuya T; Niho Y
    Rinsho Ketsueki; 1989 Mar; 30(3):400-3. PubMed ID: 2769964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic myelogenous leukemia with marked thrombocytosis].
    Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
    Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
    Jootar S
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rare Case of Pediatric Chronic Myelogenous Leukemia Presenting With Severe Thrombocytosis Without Leukocytosis.
    Huho AN; Issaq N; Iacobas I; Elghetany TM; López-Terrada D; Fisher KE; Punia JN
    Pediatr Dev Pathol; 2018; 21(1):100-104. PubMed ID: 29187020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytosis--report of a case.
    Thomas M; Pavithran K; Salil ; Somarajan A
    J Assoc Physicians India; 2000 Apr; 48(4):441-2. PubMed ID: 11273186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myeloid leukaemia with extreme thrombocytosis.
    Verma SP; Subbiah A; Jacob SE; Basu D
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26290562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic thrombocytapheresis for extreme thrombocytosis after chemotherapy in essential thrombocytosis.
    Almeida-Dias R; Garrote M; Cid J; Mustieles MJ; Alba C; Lozano M
    J Clin Apher; 2019 Aug; 34(4):503-506. PubMed ID: 30624802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing uncontrolled postsplenectomy reactive thrombocytosis in idiopathic thrombocytopenic purpura: role of thrombocytapheresis.
    Das SS; Bhattacharya S; Sen S
    Transfus Apher Sci; 2013 Oct; 49(2):171-3. PubMed ID: 23871583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plateletpheresis: Nonoperative Management of Symptomatic Carotid Thrombosis in a Patient with Reactive Thrombocytosis.
    Martínez RC; Quaynor S; Alkhalifah M; Goldenberg FD
    World Neurosurg; 2018 Jun; 114():126-129. PubMed ID: 29555611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid reduction of platelet numbers in thrombocytosis.
    Liumbruno G; Centoni PE; Ceretelli S; Sodini ML
    Ther Apher; 2000 Oct; 4(5):374-6. PubMed ID: 11111819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role for platelet apheresis for post-liver transplant thrombocytosis complicating portal vein thrombosis.
    Au WY; Liu CL; Lo CM; Fan ST; Ma SK
    J Clin Apher; 2004; 19(4):192-6. PubMed ID: 15597348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolated thrombocytosis in chronic myeloid leukemia without significant leukocytosis].
    Okano M; Sugimoto Y; Ohishi K; Miyazaki K; Monma F; Katayama N
    Rinsho Ketsueki; 2017; 58(7):766-771. PubMed ID: 28781272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and feasibility of therapeutic platelet depletion with Spectra Optia in a pregnant woman.
    Małachowski R; Grzybowska-Izydorczyk O; Besson N; Szmigielska-Kapłon A; Nowicki M; Wierzbowska A
    Transfus Apher Sci; 2017 Aug; 56(4):563-565. PubMed ID: 28803005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders.
    Baron BW; Mick R; Baron JM
    Cancer; 1993 Aug; 72(4):1209-18. PubMed ID: 8339212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.
    Boddu P; Falchi L; Hosing C; Newberry K; Bose P; Verstovsek S
    Leuk Res; 2017 Jul; 58():14-22. PubMed ID: 28380402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient.
    Ahn S; Park JS; Han JH; Cho SR
    Ann Lab Med; 2015 May; 35(3):370-2. PubMed ID: 25932449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.